Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BROMPHENIRAMINE MALEATE

BROMPHENIRAMINE MALEATE

Standard Dose
2MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BROMPHENIRAMINE MALEATE is listed in Drugs@FDA under application 087964 (ANDA).

Marketing status: Discontinued Active ingredient BROMPHENIRAMINE MALEATE Form and strength ELIXIR;ORAL - 2MG/5ML Sponsor USL PHARMA Submission history Latest submission status date: 1987-04-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview BROMPHENIRAMINE MALEATE is listed in Drugs@FDA under application 087964 (ANDA). Marketing status: Discontinued Active ingredient BROMPHENIRAMINE MALEATE Form and strength ELIXIR;ORAL - 2MG/5ML Sponsor USL PHARMA Submission history Latest submission status date: 1987-04-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.